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Abstract
Background: Plasma sialic acid is a marker of the acute phase response. Objective is to study the
relationship between sialic acid relationship with metabolic variables in Indian type 2 diabetes with
and without microvascular complications.
Research design and Methods: Fasting Venous blood samples were taken from 200 subjects of
which 50 were of diabetes mellitus (DM) and nephropathy patients, 50 patients with type 2 diabetes
and retinopathy, 50 patients with type 2 diabetes without any complications and 50 healthy
individuals without diabetes. The Indian subject's aged 15–60 years with type 2 diabetes were
recruited for the study. Simultaneously urine samples were also collected from each of the subjects.
All the blood samples were analyzed for total cholesterol, triglyceride (TG), low-density
lipoprotein (LDL), high-density lipoprotein (HDL), fasting and postprandial glucose on fully
automated analyzer. Serum and urine sialic acid along with microalbumin levels were also
estimated.
Results: There was a significantly increasing trend of plasma and urine sialic acid with severity of
nephropathy (P < 0.001) and with degree of urinary albumin excretion (P < 0.001). Serum sialic acid
correlated with increasing serum creatinine concentration (P < 0.001). Elevated serum sialic acid
concentrations were also associated with several risk factors for diabetic vascular disease: diabetes
duration, HbA1c, serum triglyceride and cholesterol concentrations, waist-to-hip ratio and
hypertension. Significant correlations were found between sialic acid concentration and
cardiovascular risk factors like LDL and TG in the diabetic subjects.
Conclusion: The main finding of this study is that elevated serum and urinary sialic acid and
microalbumin concentrations were strongly related to the presence of microvascular
complications like diabetic nephropathy and retinopathy and cardiovascular risk factors in Indian
type 2 diabetic subjects. Further study of acute-phase response markers and mediators as
indicators or predictors of diabetic microvascular complications is therefore justified.
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Introduction
Diabetes mellitus is a group of metabolic disorders char-
acterized by elevation of blood glucose concentration and
is associated with increased prevalence of microvascular
complications. Type 1 diabetes mellitus results from cellu-
lar mediated autoimmune destruction of pancreatic β-
cells of islets of langerhans and results in loss of insulin
production. Type 2 diabetes mellitus is the most common
form of diabetes accounting for 90% of cases. An esti-
mated 16 million Americans have type-2 diabetes, and
half are unaware they have it. Type 2 diabetes is character-
ized by insulin resistance or abnormal insulin secretion.
One of the more debilitating aspects of diabetes is the
numerous complications that can arise from the disease.
These complications include diabetic retinopathy, kidney
nephropathy and peripheral neuropathy. The develop-
ment and severity of these complications are dependent
on the duration of the disease and how well it is managed.
Prospective studies have reported associations among var-
ious markers of inflammation and incidence of diabetes
[1], and it has been proposed that inflammation has a
causal role in the development of diabetes [2]. Diabetes is
another risk factor for myocardial infarction and stroke
[3,4]. The relationship between diabetes and other tradi-
tional cardiovascular risk factors, e.g., an adverse lipid
profile, obesity, hypertension and physical inactivity
explain the increased risk in diabetic individuals. Even
though it has been suggested that inflammation contrib-
utes to the increased incidence of cardiovascular diseases
among diabetic subjects and only few prospective studies
have addressed this question [1]. Plasma sialic acid is one
of the markers for acute phase response [5]. Sialic acid is a
terminal component of the non-reducing end of carbohy-
drate chains of glycoproteins and glycolipids [6]. Elevated
total serum sialic acid (SA) concentration is a risk factor
for cardiovascular mortality in humans [7]. Increased
total serum sialic acid leads to increased excretion of sialic
acid in urine of the patient presented with high urinary
microalbumin.
It has been reported earlier that total serum sialic acid con-
centration increase in type 2 diabetes mellitus associated
with microvascular complications [8,9]. The aim of this
study was to measure serum and urine sialic acid and their
relation with urinary microalbumin, serum cholesterol,
TG, LDL cholesterol in diabetic subjects with and without
microvascular complications.
Microalbumin is a risk factor for cardiovascular disease; it
may be associated with chronic inflammation and inves-
tigated the relationship of urinary albumin excretion and
urinary sialic acid.
Materials and methods
We investigated the relationship of sialic acid concentra-
tions with serum lipids, and urinary albumin excretion in
Indian type 2 diabetic subjects of Kasturba Medical Col-
lege Hospital, Manipal. The study includes 200 subjects
(male and female). There were 50 healthy controls. The
diabetic subjects were divided into three groups according
to the level of complications. Group A-50 patients with
diabetes mellitus (DM) and nephropathy, group B-50
patients with type 2 diabetes and retinopathy and group-
C 50 patients with type 2 diabetes without any complica-
tions. The Indian subject's aged 15–60 years with type 2
diabetes were recruited for the study. The estimation of
serum and urine sialic acid may prove to predictive and
preventive of microvascular diseases and their complica-
tions in people with type 2 diabetes.
All the subjects were reported fasting in the morning after
10–12 hr overnight fast. Standing height and weight were
measured. Body mass Index (BMI) defined as weight in
kg/height (in meters) squared was calculated, and used as
an index for obesity. Measurements of the waist circum-
ference were taken at the mid point between umbilicus
and xiphoid, and for hip circumference at the widest point
around the hips. The waist hip ratio was thereafter calcu-
lated [10]. Blood pressure was measured according to the
standard procedure [11].
Venous blood samples collected without the use of tour-
niquet from each of the patients were analyzed for total
serum cholesterol, TG, LDL, HDL, fasting and postpran-
dial glucose on fully automated analyzer (Hitachi 912
analyzer, Roche, Switzerland) with the reagents supplied
by Roche. The HbA1c is estimated with the principle
based on affinity chromatography technique.
Serum and urinary sialic acid was measured by a colori-
metric assay using standard chemicals and reagents. In
this method a protein precipitate of serum containing
sialic acid will react with diphenylamine producing a pur-
ple color, which is quantitatively measured on a spectro-
photometer at 540 nm.
The fresh urine samples collected from the test and con-
trol group subjects were used for microalbumin estima-
tion in an electrochemiluminiscence analyzer (Roche,
Switzerland).
Statistical Method
Results were expressed as mean ± S.D. except where other-
wise stated. Data were analyzed using the statistical pack-
age for social science, SPSS and p value ≤ 0.05 was taken
as the cut off level for significance. Because the distribu-
tion of most variables was not symmetric. We used non-Lipids in Health and Disease 2005, 4:15 http://www.lipidworld.com/content/4/1/15
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parametric statistical methods. Chi square tests was be
used to examine, type 2 diabetes mellitus, the various clin-
ical and biochemical markers.
Results
The table 1 shows the relationship between serum sialic
acid, urine sialic acid and microalbumin concentrations
with metabolic variables in diabetic subjects with and
without microvascular complications. The table depicts
significant increase of serum sialic acid (< 0.001) among
the Indian diabetic subjects compared to the control sub-
jects. Furthermore, in the diabetic subjects urine sialic acid
and microalbumin were significantly higher (< 0.001).
The Table also shows the association of sialic acid and sev-
eral risk factors for diabetic vascular disease; diabetes
duration, serum TG and cholesterol concentration. It is
observed that the sialic acid values were statistically signif-
icantly higher with increasing urinary albumin excretion
(p < 0.001). Similarly HbA1c, FBS, PPBS, TG and choles-
terol showed marked increase in patients with elevated
level of microalbumin and urine sialic acid when com-
pared to normal subjects without any complications.
Discussion
In recent years, much attention has been given to the rela-
tionships among adiposity, inflammation, and diabetes.
High inflammation sensitive plasma protein levels
increased the cardiovascular risk slightly more in diabetic.
Studies of diabetic subjects have reported increased inci-
dences of cardiovascular diseases or increased diabetes
complications among subjects with high fibrinogen [12]
and other markers of inflammation [13,14]. Measure-
ment of inflammation sensitive markers may be useful for
assessment of the cardiovascular risk in diabetic patients.
Results from prospective studies suggest that inflamma-
tion involved in the pathogenesis of diabetes [15] and
atherosclerosis [16]. Inflammation could be a common
antecedent for both diabetes and cardiovascular disease.
Hyperglycemia and insulin resistance could also promote
inflammation, and may be factor linking diabetes to the
development of atherosclerosis. Elevated glucose levels
could promote inflammation by increased oxidative stress
[17]. Yet another possibility is that the inflammatory
response is a result of vascular complications following
diabetes. In type-2 diabetes, the circulating sialic acid con-
centration is elevated in comparison with non-diabetic
subjects [18]. The results of our study showed serum and
urine SA concentration increased in diabetic patients as
compared to the general population, especially in type-2
diabetic patients with either microalbuminuria or albu-
minuria. Furthermore, the serum and urine sialic acid lev-
els were independent of the duration of diabetes mellitus
and degree of metabolic control (as estimated by HbA1c).
Also, a good correlation was observed between sialic acid
and important cardiovascular risk factors such as choles-
terol, LDL and TG.
It has been reported that serum sialic acid levels are
increased in type1 DM patients with albuminuria [19].
Several authors found the increased urinary concentration
of sialic acid in type 2 diabetes with microangiopathy. The
vascular permeability is regulated by sialic acid moieties,
with increased vascular permeability resulting from the
shedding of vascular endothelial sialic acid into the circu-
lation. It is well established that vascular endothelium car-
ries a high level of sialic acid [20], and the vascular
damage leads to its release into the circulation. A relation-
ship between serum sialic acid levels and microvascular
complications has been observed before for microalbu-
minuria and clinical proteinuria in type 1 [21] and type 2
diabetes [22].
Table 1: Serum and urinary sialic acid and microalbumin levels in Type 2 diabetes with nephropathy and retinopathy
Parameters Diabetes without any 
complications
Diabetic nephropathy Diabetic Retinopathy Non-diabetic subjects p value
Serum Sialic acid (mg%) 55.05 ± 2.9* 85.05 ± 2.7*** 75.05 ± 2.5*** 46.6 ± 2.08 < 0.001
Urine sialic acid (mg%) 6.02 ± 2.58** 13.06 ± 1.58*** 11.03 ± 1.78*** 3.2 ± 0.65 < 0.001
Microalbumin (mg %) 8.2 ± 3.24 132.2 ± 35.24*** 102.2 ± 29.24*** 7.67 ± 3.28 < 0.001
FBS (mg%) 140.02 ± 70.08 155.6 ± 50.7 150.6 ± 49.9 90.02 ± 80.08 < 0.01
PPBS (mg%) 150.02 ± 102.10 207.3 ± 57.6 200.1 ± 57.6 120.02 ± 102.10 < 0.01
HbA1C (%) 9.10 ± 5.20 11.1 ± 2.3 10.1 ± 2.5 6.10 ± 5.20 < 0.05
Triglyceride (mg%) 122.04 ± 75.01 178.02 ± 78.01 180.04 ± 75.01 120.04 ± 76.01 < 0.05
Cholesterol(mg%) 148.04 ± 120.01 256.03 ± 134.01 246.03 ± 130.01 140.04 ± 119.01 NS
HDL (mg %) 35.01 ± 20.04 38.01 ± 26.02 35.01 ± 20.04 36.01 ± 19.04 NS
LDL (mg %) 90.00 ± 76.06 165.00 ± 97.01 160.00 ± 95.01 87.00 ± 76.05 < 0.05
Creatinine (mg %) 2.00 ± 1.6.06 10.05 ± 2.03 10.03 ± 2.01 1.40 ± 1.20 < 0.001
Urine creatinine (mg%) 145.00 ± 102.6 155.03 ± 65.02 150.03 ± 66.01 146.00 ± 113.06 < 0.05
Mean ± SD *** p < 0.001, NS = not significant, n = 50Publish with BioMed Central    and   every 
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Our findings clearly indicated that serum and urinary
sialic acid concentrations were elevated in type-2 diabetes.
Crook M et.al found that serum sialic acid was signifi-
cantly higher in men with diabetic complications than in
those without any of the complications [23]. There may
be an association between sialic acid and complications
through the acute phase response.
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